Non-Melanoma Skin Cancer: Advances Towards Prevention and Personalized Medicine in Clinical Practice
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 529
Special Issue Editors
Interests: dermatology; photobiology; photodynamic therapy; phototherapy; cutaneous skin cancer; complex dermatology
Interests: photobiology; photoimmunology; phototherapy; targeted therapies; photobiomodulation; wound healing; basic sciences
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Non-melanoma skin cancer (NMSC) is the most frequent tumor in humans. NMSC exhibits a special behavior, not only emerging through the classical route of accumulated mutation, but also via alternative pathways. Clinician still do not know how to predict the evolution of precancerous lesions, the actinic keratosis (AK), or the reason for the polarized clinical presentation of cutaneous T-cell lymphoma (LCCT). Apart from the lack of feasible indicators of progressive potential, NMSC shows a varied response to treatment in dermatological practice, and a necessity for personalized medicine has arisen.
We are pleased to invite you to participate in this Special Issue focused on NMSC prevention and treatment based on translational strategies with real-practice clinical application. This Special Issue is open and practical, with the purpose of linking clinical practice with basic science. Clinicians and researchers are encouraged to share their detailed experience, including negative or null results.
This Special Issue aims to:
- Expand the knowledge of novel clinical strategies for NMSC treatment and prevention.
- Share new targeted therapies in NMSC with the scientific community.
- Be a connector between dermatologists and basic research.
In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Montserrat Fernández-Guarino
Dr. Stefano Bacci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-melanoma skin cancer (NMSC)
- actinic keratosis (AK)
- basal cell carcinoma (BCC)
- epidermoid carcinoma (EC)
- Bowen disease (BD)
- Merkel carcinoma (MC)
- cutaneous T-cell lymphoma (CTCL)
- cutaneous B-cell lymphoma (CBLL)
